Why Changes are needed to Current Preformulation and Formulation Practices
As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are needed to current preformulation and formulation practices, strategies to reduce time spent in R&D and importance of the role of co-crystals in formulation design and product development. Horspool also shares his top 3 tips for evaluating the potential of new drug delivery techno...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.